Published in Cancer Res on September 15, 1999
Cripto-1 activates nodal- and ALK4-dependent and -independent signaling pathways in mammary epithelial Cells. Mol Cell Biol (2002) 1.53
TGF-β superfamily member Nodal stimulates human β-cell proliferation while maintaining cellular viability. Endocrinology (2013) 1.53
Lefty blocks a subset of TGFbeta signals by antagonizing EGF-CFC coreceptors. PLoS Biol (2004) 1.19
Cripto binds transforming growth factor beta (TGF-beta) and inhibits TGF-beta signaling. Mol Cell Biol (2006) 1.15
Emerging roles of nodal and Cripto-1: from embryogenesis to breast cancer progression. Breast Dis (2008) 1.03
Nodal and lefty signaling regulates the growth of pancreatic cells. Dev Dyn (2008) 0.96
Cripto/GRP78 modulation of the TGF-β pathway in development and oncogenesis. FEBS Lett (2012) 0.91
Anti-Cripto Mab inhibit tumour growth and overcome MDR in a human leukaemia MDR cell line by inhibition of Akt and activation of JNK/SAPK and bad death pathways. Br J Cancer (2007) 0.89
Inhibitory phosphorylation of GSK-3β by AKT, PKA, and PI3K contributes to high NaCl-induced activation of the transcription factor NFAT5 (TonEBP/OREBP). Am J Physiol Renal Physiol (2013) 0.88
Regulation of extra-embryonic endoderm stem cell differentiation by Nodal and Cripto signaling. Development (2011) 0.86
Regulation of Cripto-1 signaling and biological activity by caveolin-1 in mammary epithelial cells. Am J Pathol (2008) 0.83
Decrypting the role of Cripto in tumorigenesis. J Clin Invest (2003) 0.81
Cripto-1 overexpression is involved in the tumorigenesis of nasopharyngeal carcinoma. BMC Cancer (2009) 0.79
Autoregulation and heterogeneity in expression of human Cripto-1. PLoS One (2015) 0.76
Tumorigenic factor CRIPTO-1 is immunolocalized in extravillous cytotrophoblast in placenta creta. Biomed Res Int (2014) 0.75
A population of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. I. Separation and characterization. J Exp Med (1970) 15.86
Studies of the macrophage complement receptor. Alteration of receptor function upon macrophage activation. J Exp Med (1975) 7.87
Binding of sheep red blood cells to a large population of human lymphocytes. Nature (1971) 7.67
Enhanced binding of neuraminidase-treated sheep erythrocytes to human T lymphocytes. Blood (1973) 4.99
Receptors for cold-insoluble globulin (plasma fibronectin) on human monocytes. J Exp Med (1981) 3.93
Idiopathic hypertrophic subaortic stenosis. Clinical analysis of 126 patients with emphasis on the natural history. Circulation (1968) 3.82
Characterization of the macrophage receptro for complement and demonstration of its functional independence from the receptor for the Fc portion of immunoglobulin G. J Exp Med (1975) 3.80
Theta-bearing and complement-receptor lymphocytes are distinct populations of cells. Science (1971) 3.16
CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. Neurology (2012) 3.12
Mechanism of binding of soluble immune complexes to lymphocytes. Cell Immunol (1973) 2.93
Studies on the selective lysis and purification of Trypanosoma cruzi. J Exp Med (1975) 2.54
Cell surface immunoglobulin. IV. Distribution among thymocytes, bone mrrow cells, and their derived populations. J Exp Med (1972) 2.50
Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: prolonged persistence of neutrophils and macrophages during the late phase of repair. J Invest Dermatol (2000) 2.42
The induction of macrophage spreading: role of coagulation factors and the complement system. J Exp Med (1976) 2.41
Transmission of glioblastoma multiforme through liver transplantation. Lancet (1998) 2.33
Tissue localization of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. Proc Natl Acad Sci U S A (1970) 2.29
Volunteering for early phase gene transfer research in Parkinson disease. Neurology (2006) 2.27
Increased proportion of complement-receptor lymphocytes in the peripheral blood of patients with chronic lymphocytic leukemia. Blood (1972) 2.25
Cooperative inhibitory effect of ZD1839 (Iressa) in combination with trastuzumab (Herceptin) on human breast cancer cell growth. Ann Oncol (2002) 2.14
Pregnancy outcome following maternal exposure to statins: a multicentre prospective study. BJOG (2012) 2.14
Discovery of a Jupiter/Saturn analog with gravitational microlensing. Science (2008) 2.09
A phase II study of vinflunine in bladder cancer patients progressing after first-line platinum-containing regimen. Br J Cancer (2006) 1.85
Management and outcome of CSF-JC virus PCR-negative PML in a natalizumab-treated patient with MS. Neurology (2011) 1.83
Bone marrow origin of complement-receptor lymphocytes. Eur J Immunol (1971) 1.80
Bv8, a small protein from frog skin and its homologue from snake venom induce hyperalgesia in rats. Eur J Pharmacol (1999) 1.74
Copper induction of laccase isoenzymes in the ligninolytic fungus Pleurotus ostreatus. Appl Environ Microbiol (2000) 1.69
Differential response to growth factor by rat mammary epithelium plated on different collagen substrata in serum-free medium. Proc Natl Acad Sci U S A (1981) 1.69
Target-based agents against ErbB receptors and their ligands: a novel approach to cancer treatment. Endocr Relat Cancer (2003) 1.67
Immune phagocytosis in murine malaria. J Exp Med (1979) 1.66
Natural history of inoperable hepatocellular carcinoma: estrogen receptors' status in the tumor is the strongest prognostic factor for survival. Hepatology (2000) 1.64
Providing a complete online multimedia patient record. Proc AMIA Symp (1999) 1.60
Expression of transforming growth factor alpha and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its possible functional significance. Mol Endocrinol (1988) 1.59
The ErbB receptors and their ligands in cancer: an overview. Curr Drug Targets (2005) 1.59
Counterregulation of interleukin-18 mRNA and protein expression during cutaneous wound repair in mice. J Invest Dermatol (1999) 1.58
Effect of cadmium on estrogen receptor levels and estrogen-induced responses in human breast cancer cells. J Biol Chem (1994) 1.53
Assessing prognosis and optimizing treatment in patients with postchemotherapy viable nonseminomatous germ-cell tumors (NSGCT): results of the sCR2 international study. Ann Oncol (2007) 1.52
Testicular torsion: late results with special regard to fertility and endocrine function. J Urol (1980) 1.52
Differential expression of epidermal growth factor-related proteins in human colorectal tumors. Proc Natl Acad Sci U S A (1991) 1.52
A novel white laccase from Pleurotus ostreatus. J Biol Chem (1997) 1.52
Use of a carotid artery for arterial cannulation: side-related differences. Thorac Cardiovasc Surg (2010) 1.51
The induction of macrophage spreading by factor B of the properdin system. J Exp Med (1979) 1.50
Betacellulin and activin A coordinately convert amylase-secreting pancreatic AR42J cells into insulin-secreting cells. J Clin Invest (1996) 1.49
Gene therapy of liver tumors with human liver-specific nanoparticles. Cancer Gene Ther (2006) 1.46
The role of EGF-related peptides in tumor growth. Front Biosci (2001) 1.45
Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer. Ann Oncol (2012) 1.44
Complement receptors. Contemp Top Mol Immunol (1977) 1.44
Adenovirus-mediated rescue of lipoprotein lipase-deficient mice. Lipolysis of triglyceride-rich lipoproteins is essential for high density lipoprotein maturation in mice. J Biol Chem (2001) 1.43
Concurrent nitroglycerin administration reduces the efficacy of recombinant tissue-type plasminogen activator in patients with acute anterior wall myocardial infarction. Am Heart J (1995) 1.39
Measures to decrease the risk of acquired immunodeficiency syndrome transmission by blood transfusion. Evidence of volunteer blood donor cooperation. Transfusion (1985) 1.36
Pancreatic intraepithelial neoplasia revisited and updated. Pancreatology (2008) 1.35
Autopsy findings in 111 cases of esophageal cancer. Cancer (1981) 1.34
Identification of the motility-related protein (MRP-1), recognized by monoclonal antibody M31-15, which inhibits cell motility. J Exp Med (1991) 1.34
The function of nitric oxide in wound repair: inhibition of inducible nitric oxide-synthase severely impairs wound reepithelialization. J Invest Dermatol (1999) 1.29
Regulation of macrophage migration by products of the complement system. Proc Natl Acad Sci U S A (1979) 1.29
C3 split products inhibit the binding of antigen-antibody-complement complexes to B lymphocytes. J Immunol (1973) 1.28
Suppressor cell function defect in idiopathic systemic lupus erythematosus. Clin Immunol Immunopathol (1979) 1.28
A population of lymphocytes bearing a membrane receptor antigen-antibody-complement complexes. II. Specific isolation. Cell Immunol (1971) 1.27
Leukemic cells with membrane properties of thymus-derived (T) lymphocytes in a case of Sézary's syndrome: morphologic and immunologic studies. Clin Immunol Immunopathol (1973) 1.27
Epidermal growth factor receptor, but not c-erbB-2, activation prevents lactogenic hormone induction of the beta-casein gene in mouse mammary epithelial cells. Mol Cell Biol (1990) 1.26
Inhibition of proteolysis protects hippocampal neurons from ischemia. Proc Natl Acad Sci U S A (1991) 1.25
Monocyte receptors for fibronectin characterized by a monoclonal antibody that interferes with receptor activity. J Exp Med (1985) 1.25
Specific receptors for phorbol esters in lymphoid cell populations: role in enhanced production of T-cell growth factor. Proc Natl Acad Sci U S A (1981) 1.24
Molecular cloning of ILP-2, a novel member of the inhibitor of apoptosis protein family. Mol Cell Biol (2001) 1.23
The EGF-CFC family: novel epidermal growth factor-related proteins in development and cancer. Endocr Relat Cancer (2000) 1.22
Value of glycosylated hemoglobin measurements after acute myocardial infarction. JAMA (1981) 1.22
Tissue-specific expression of pancreatic-type RNases and RNase inhibitor in humans. DNA Cell Biol (1997) 1.22
Presence of transforming growth factors in human breast cancer cells. Cancer Res (1984) 1.21
Expression and release of IL-18 binding protein in response to IFN-gamma. J Immunol (2001) 1.19
Spectrum of clinical variability in familial deletion 22q11.2: from full manifestation to extremely mild clinical anomalies. Clin Genet (2003) 1.18
Differential immunohistochemical detection of amphiregulin and cripto in human normal colon and colorectal tumors. Cancer Res (1992) 1.17
Additive effects of c-erbB-2, c-Ha-ras, and transforming growth factor-alpha genes on in vitro transformation of human mammary epithelial cells. Mol Carcinog (1992) 1.17
Scavenger receptor class B, type I is expressed in porcine brain capillary endothelial cells and contributes to selective uptake of HDL-associated vitamin E. J Neurochem (2001) 1.16
Tropomyosins of human mammary epithelial cells: consistent defects of expression in mammary carcinoma cell lines. Cancer Res (1990) 1.16
Steroid receptors and steroid response in cultured L1210 murine leukemia cells. Mol Cell Endocrinol (1979) 1.15
Interaction and release of soulble immune complexes from mouse B luymphocytes. Cell Immunol (1973) 1.14
Maximising the duration of disease control in metastatic renal cell carcinoma with targeted agents: an expert agreement. Med Oncol (2011) 1.14
Heterodimerization of a functional GABAB receptor is mediated by parallel coiled-coil alpha-helices. Biochemistry (1999) 1.14
Proteomic study of salivary peptides and proteins in patients with Sjögren's syndrome before and after pilocarpine treatment. Arthritis Rheum (2007) 1.14
Biomonitoring of exposure to polycyclic aromatic hydrocarbons of nonoccupationally exposed persons. Cancer Epidemiol Biomarkers Prev (2000) 1.14
Antitumor activity of combined blockade of epidermal growth factor receptor and protein kinase A. J Natl Cancer Inst (1996) 1.13
Single nucleotide polymorphism D1853N of the ATM gene may alter the risk for breast cancer. J Cancer Res Clin Oncol (2008) 1.13
A cadaver workshop to teach medical procedures. Med Educ (1986) 1.13
Autocrine action of amphiregulin in a colon carcinoma cell line and immunocytochemical localization of amphiregulin in human colon. J Cell Biol (1992) 1.13
Effect of 12-O-tetradecanoylphorbol-13-acetate (TPA) on the growth inhibitory and increased phosphatidylinositol (PI) responses induced by epidermal growth factor (EGF) in A431 cells. J Cell Physiol (1983) 1.12
Estrogen and phorbol esters regulate amphiregulin expression by two separate mechanisms in human breast cancer cell lines. Endocrinology (1995) 1.11
Expressional regulation of angiopoietin-1 and -2 and the tie-1 and -2 receptor tyrosine kinases during cutaneous wound healing: a comparative study of normal and impaired repair. Lab Invest (2001) 1.11
Fibronectin receptors of mononuclear phagocytes: binding characteristics and biochemical isolation. Exp Cell Res (1989) 1.11
Natural history of valvular aortic stenosis. Br Heart J (1973) 1.11
Isolation and characterization of the human forkhead gene FOXQ1. DNA Cell Biol (2001) 1.10
Differentiation stimuli induce receptors for plasma fibronectin on the human myelomonocytic cell line HL-60. Blood (1984) 1.10
Plasma membrane polypeptides of resident and activated mouse peritoneal macrophages. Proc Natl Acad Sci U S A (1980) 1.10